Novogene is a global leader in multiomics services, offering comprehensive solutions in genomics, transcriptomics, epigenomics, proteomics, metabolomics, and bioinformatics. With one of the world’s largest sequencing capacities and labs across continents, Novogene enables coordinated multiomics workflows through a single provider. Backed by 70+ patents and 30,000+ publications in leading journals, and using platforms like Illumina, PacBio, Oxford Nanopore, 10X Genomics, and Olink®, Novogene supports research across academic, clinical, and pharmaceutical fields worldwide.